Navigation Links
CV Ingenuity Announces Close of $16 Million Series B Financing Led by NEA
Date:10/4/2011

MENLO PARK, Calif., Oct. 4, 2011 /PRNewswire/ -- CV Ingenuity, a privately-held medical device company, today announced the close of a $16 million Series B round of financing led by New Enterprise Associates (NEA), a leading global venture capital firm. Existing investors BioStar Ventures, Synergy Ventures and Western Technology also participated in the round. CV Ingenuity (CVI), which is focused on the development of a drug-eluting balloon platform technology that aims to treat peripheral artery disease while also working to prevent restenosis, will use this latest round of funding to accelerate product development and expand the leadership team.  

"I am extremely pleased with the significant financial commitment that NEA and our existing investors have made to CVI in this funding round," said CEO Duke Rohlen. "Their financial support is further validation of our technology, our leadership team and our strategy to develop a drug eluting balloon technology to treat patients suffering from peripheral artery disease. We are thrilled to partner with these blue-chip investors as we accelerate into clinical development."

The afflicted patient population that CVI's technology will treat is substantial. It is estimated that PAD currently affects between eight and 12 million adults-and is the leading cause of amputation in patients over 50. Hospitalization costs of PAD alone are estimated to exceed $21 billion annually.

"CVI is addressing an important and overlooked disease within a market that has an estimated $1 billion potential," said NEA General Partner Ryan Drant. "They have developed an extremely sound technology platform and have a tremendously talented and resourceful team that is now in a position to expand and rapidly develop this promising device." Mr. Drant and Justin Klein, a principal with NEA, will join the CVI Board of Directors.

About CV Ingenuity

CV Ingenuity is a Palo Alto, CA based medical device compa
'/>"/>

SOURCE CV Ingenuity
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Ingenuity Announces New Additional MicroRNA Content to Complement First-of-its-Kind MicroRNA Filtering Capability in IPA
2. Ingenuity Announces RNA-Sequencing Workflow Support and First-of-Its-Kind microRNA Filtering Capability With Latest Release of IPA
3. Ingenuity Systems and TransMed Systems Integrate Software to Support Personalized Medicine Research
4. Medical Alarm Concepts Announces Beta Testing of Next Generation MediPendant™ Medical Alarm Technology!
5. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2011 Results
6. Varian Medical Systems Announces New Management Positions
7. The Law Firm of Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches of Fiduciary Duty by the Board of Pharmaceutical Product Development, Inc. in Connection With Sale of the Company to The Carlyle Group and Hellman & Friedman
8. PAREXEL Announces Date of First Quarter Fiscal Year 2012 Earnings Release and Conference Call
9. Concord Medical Services Announces Share Repurchase Program
10. Sysmex Announces Newest Version of Clinical Laboratory Management Software
11. Atrium Announces the Publication of the COBEST Trial by the Journal of Vascular Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... YORK , Dec. 17, 2014 ... imaging (MRI), the MRI market is seeing new ... and breast MRI scans account for the majority ... a higher resolution of images, which are creating opportunities ... imaging (MRI) market is growing at a rate ...
(Date:12/17/2014)... -- , The new Dompé ... information concerning the biopharmaceutical Group,s national and international clinical research ... the recently launched institutional website that is receiving accolades from ... a new chapter in the fascinating story of Drug Discovery ... panoramic hub on the world of clinical research, ranging from ...
(Date:12/17/2014)... BUENA, N.J. , Dec. 17, 2014  IGI ... announced today the closing of its offering of $125 ... due 2019 (the "Notes").  The Notes were offered and ... 144A under the Securities Act of 1933, as amended ... at a fixed rate of 3.75% per year, payable ...
Breaking Medicine Technology:Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4
... , Rochester Medical Corporation (Nasdaq: ROCM ) will ... 2009. The Company will then hold a quarterly conference call ... 3:30 p.m. central time (4:30 p.m. eastern time). , This call ... Medical,s website at www.rocm.com . To listen ...
... Oct. 28 Qualsec (OTC Bulletin Board: QLSZ), which recently ... has been elected as a member of the Board of ... of clinical experience followed by 6 years of medical device ... and only FDA cleared RFID medical information device of its ...
Cached Medicine Technology:Rochester Medical Announces Fourth Quarter 2009 Earnings Conference Call Thursday, November 5th 2009 2VitaminSpice Appoints Dr. Richard F. Seelig as Director 2
(Date:12/17/2014)... HealthDay Reporter TUESDAY, Dec. ... fast approaching, a new study reveals that states that routinely ... drunk drivers on their roads. The finding suggests that ... able to deter inebriated revelers from getting behind the wheel ... being passed regarding drinking and driving," said study lead author ...
(Date:12/15/2014)... Cancer researchers have just published an ... of deadly malignant pleural mesothelioma. Surviving Mesothelioma has just ... Click here to read it now. , ... Center, and New York’s Langone Medical Center performed complete ... in an effort to pinpoint the genes that ...
(Date:12/15/2014)... SIMpalm, a leading mobile app development company , ... client, which allows users to keep track of wines ... the right wine. At the center of WineMatch ... and wine information. All this information is assembled to ... that are close counterparts to one another are called ...
(Date:12/15/2014)... SUNDAY, Dec. 14, 2014 (HealthDay News) -- Expert pilots ... which explains why they make better decisions during landings, ... the most difficult techniques for pilots to master, and ... of fatal crashes occur during final approach and landing. ... pilots and 12 moderately experienced pilots while they were ...
(Date:12/15/2014)... 15, 2014 In support of ... attention to restrictive state laws that may have ... this important area of public health policy. , ... the Integrity of Independent Review, contends that state ... independent peer review determinations can result in subpar ...
Breaking Medicine News(10 mins):Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 3Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:Use WinMatch Connect App to Keep Track of Wines You Like 2Health News:Study Shows Why Expert Pilots Are Experts 2Health News:NAIRO Calls for Higher Quality Independent Peer Review By Ending Restrictive State Laws 2
... geared to genetic blueprints from Elite Books, TUCSON, Ariz., ... It,plays a key role in the development of Alzheimer,s Disease ... it is greatly affected,by diet. In her seminal book, ... Heart and Alzheimer,s Using the Body,s Own Genes,(Elite, Hardcover, $27.95, ...
... FRAMINGHAM, Mass., Nov. 5 StatSure Diagnostic,Systems, Inc. ... U.S.,Food and Drug Administration ("FDA"), through its Center ... under the Clinical Laboratory,Improvements Amendments of 1988 ("CLIA") ... patented "barrel" technology. The HIV 1/2 product,is marketed ...
... to place systems in more physician offices could ... of underserved patient populations, NEW YORK, Nov. 5 ... New York (HIP) will convene an educational seminar in,New ... treating,underserved patient populations. The seminar, to be held at ...
... Research Findings to Impact Human Health, Agricultural Science, ... Beauty announced that they successfully sequenced the complete ... fungus,responsible for the onset of dandruff and other ... are published in today,s online edition of,Proceedings of ...
... 5 Millennium,Pharmaceuticals, Inc. (Nasdaq: MLNM ) ... Suisse Healthcare Conference will be webcast live and,may ... the Company,s website, http://www.millennium.com . (Logo: ... an overview of the Company, an update on,clinical ...
... to Compulsory Acquisition, WARSAW, Ind. and MONTREAL, Nov. ... ZMH), a leader in the orthopaedics,industry, and its indirect ... pursuant to the extension of the Offer,made for all ... a leader in computer navigation for orthopaedic,surgery, it has ...
Cached Medicine News:Health News:Groundbreaking Apo E Gene Diet Linked to Alzheimer's Disease and Heart Disease Prevention 2Health News:StatSure's Patented HIV 'Barrel' Technology Receives CLIA Waiver From FDA 2Health News:StatSure's Patented HIV 'Barrel' Technology Receives CLIA Waiver From FDA 3Health News:GHI and HIP Lead Effort to Expand Electronic Health Record System Throughout the City of New York 2Health News:Photo: Scientists Complete Genome Sequence of Fungus Responsible for Dandruff, Skin Disorders 2Health News:Photo: Scientists Complete Genome Sequence of Fungus Responsible for Dandruff, Skin Disorders 3Health News:2007 Credit Suisse Healthcare Conference to Webcast Millennium Presentation 2Health News:Zimmer Announces Successful Completion of ORTHOsoft Takeover Bid 2Health News:Zimmer Announces Successful Completion of ORTHOsoft Takeover Bid 3
3 mm diameter roller blade, 15 mm from angle to tip. Round handle....
2 mm wide x 3 mm long, with rounded triangular tip. Angled 45 degrees. Hexagonal handle....
Duckbill type sharp. 3 mm wide x 8 mm long curved blade. Octagonal handle....
9 mm slightly curved blade. Hexagonal handle....
Medicine Products: